BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36306202)

  • 1. Distant metastases in human papillomavirus-related oropharyngeal squamous cell carcinoma: Systematic review and meta-analysis.
    Crossley JR; Nelson LL; Chou J; Maxwell JH
    Head Neck; 2023 Jan; 45(1):275-282. PubMed ID: 36306202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic evaluation and meta-analysis of the prognosis of down-staging human papillomavirus (HPV) positive oropharyngeal squamous cell carcinoma using cetuximab combined with radiotherapy instead of cisplatin combined with radiotherapy.
    Hu Q; Li F; Yang K
    PeerJ; 2024; 12():e17391. PubMed ID: 38784388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of oropharyngeal squamous cell carcinoma stratified by human papillomavirus subtype: A systematic review and meta-analysis.
    Shenker RF; Razavian NB; D'Agostino RB; Mowery YM; Brizel DM; Hughes RT
    Oral Oncol; 2024 Jan; 148():106644. PubMed ID: 38006690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global prevalence of human papillomavirus-related oral and oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis.
    Fonsêca TC; Jural LA; Marañón-Vásquez GA; Magno MB; Roza ALOC; Ferreira DMTP; Maia LC; Romañach MJ; Agostini M; Abrahão AC
    Clin Oral Investig; 2023 Dec; 28(1):62. PubMed ID: 38158517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing distant metastases and survival in oropharyngeal squamous cell carcinoma.
    Saiyed FK; Guo T; Johnson F; Myers JN
    Head Neck; 2021 Jul; 43(7):2101-2109. PubMed ID: 33738875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of reduced- versus standard-dose radiotherapy on survival and radiation-associated toxicity in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review protocol.
    Lee TJ; Krishnan G; Ooi EH; Barker TH
    JBI Evid Synth; 2022 Apr; 20(4):1135-1141. PubMed ID: 34698708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of clinical evaluation of individuals with increased risk for HPV-associated oropharynx cancer.
    Scott-Wittenborn N; D'Souza G; Aygun N; Tewari SR; Azadi J; Vosler P; Gooi Z; Mehta V; Mydlarz W; Nance M; Mlot S; Patel MR; Tan M; Miles BA; Troy T; Fakhry C
    Head Neck; 2023 Jan; 45(1):95-102. PubMed ID: 36200696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Delay in Human Papillomavirus Negative Oropharyngeal Squamous Cell Carcinoma.
    Karp EE; Yin LX; O'Byrne TJ; Lu LY; Routman DM; Lester SC; Neben Wittich MA; Ma DJ; Price KA; Chintakuntlawar AV; Tasche KK; Price DL; Moore EJ; Van Abel KM
    Laryngoscope; 2023 Jun; 133(6):1394-1401. PubMed ID: 35851669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated disease.
    Bartemes KR; Gochanour BR; Routman DM; Ma DJ; Doering KA; Burger KN; Foote PH; Taylor WR; Mahoney DW; Berger CK; Cao X; Then SS; Haller TJ; Larish AM; Moore EJ; Garcia JJ; Graham RP; Bakkum-Gamez JN; Kisiel JB; Van Abel KM
    Oral Oncol; 2023 Nov; 146():106568. PubMed ID: 37717549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus co-infection and survival in oral and oropharyngeal squamous cell carcinoma: A study in 235 Brazilian patients.
    Silveira HA; Almeida LY; Carlos R; Silva EV; Ferrisse TM; Duarte A; Cardoso SCS; Polanco XBJ; Bufalino A; Ribeiro-Silva A; León JE
    Auris Nasus Larynx; 2022 Apr; 49(2):258-270. PubMed ID: 34274177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Incidence, Survival, and HPV Impact of Second Primary Cancer following Primary Oropharyngeal Squamous Cell Carcinoma: A 20-Year Retrospective and Population-Based Study.
    Andersen L; Jakobsen KK; Carlander AF; Garset-Zamani M; Friborg J; Kiss K; Marvig RL; Olsen C; Nielsen FC; Andersen E; Grønhøj C; Buchwald CV
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
    Trosman SJ; Koyfman SA; Ward MC; Al-Khudari S; Nwizu T; Greskovich JF; Lamarre ED; Scharpf J; Khan MJ; Lorenz RR; Adelstein DJ; Burkey BB
    JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):457-62. PubMed ID: 25742025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to prevent human papillomavirus-related oropharyngeal cancer?
    Ferrando-Díez A; Pavón MA; Cirauqui B; Alemany L; Mesía R
    Curr Opin Oncol; 2023 May; 35(3):145-150. PubMed ID: 36966500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of human papillomavirus status on prognosis and local treatment strategies of T1-2N0 oropharyngeal squamous cell cancer.
    Zhou P; Chen DL; Lian CL; Wu SG; Zhang SY
    Front Public Health; 2022; 10():900294. PubMed ID: 35958856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review on location and timing of distant progression in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas.
    Tiedemann D; Jakobsen KK; von Buchwald C; Grønhøj C
    Head Neck; 2019 Mar; 41(3):793-798. PubMed ID: 30582231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy.
    Morbini P; Alberizzi P; Ferrario G; Capello G; De Silvestri A; Pedrazzoli P; Tinelli C; Benazzo M
    Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):9-17. PubMed ID: 30936574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
    Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Papillomavirus Impact on Temporal Treatment Trends in Oropharyngeal Carcinoma: 2010-2016.
    Amin N; Thompson J; Goloubeva O; Witek M; Taylor RJ; Wolf JS; Moyer K; Mehra R; Hatten KM
    ORL J Otorhinolaryngol Relat Spec; 2022; 84(6):438-446. PubMed ID: 36067748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Liquid Biopsy for Diagnosis and Surveillance of Human Papillomavirus-Associated Oropharyngeal Cancer.
    Ferrandino RM; Chen S; Kappauf C; Barlow J; Gold BS; Berger MH; Westra WH; Teng MS; Khan MN; Posner MR; Misiukiewicz KJ; Bakst RL; Sindhu KK; Genden EM; Chai RL; Roof SA
    JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):971-977. PubMed ID: 37422913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical margin status and role of adjuvant therapy in human papillomavirus-positive oropharyngeal cancer.
    Park YM; Lim JY; Koh YW; Choi EC; Kim SH
    Head Neck; 2023 Sep; 45(9):2369-2376. PubMed ID: 37489048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.